Hims & Hers Health, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 271.88M | 526.92M | 872.00M | 1.48B | 2.35B | 59.0% | |
| Cost of Revenue | (67.38M) | (118.19M) | (157.05M) | (303.38M) | (614.26M) | 102.5% | |
Gross Profit | 204.49M | 408.72M | 714.95M | 1.17B | 1.73B | 47.8% | |
| Operating Expenses | |||||||
| Research & Development | (22.38M) | (29.24M) | (48.23M) | (78.82M) | (149.30M) | 89.4% | |
| Selling, General & Administrative | (249.56M) | (370.78M) | (576.32M) | (846.61M) | (1.19B) | 40.8% | |
| General & Administrative | (113.66M) | (98.19M) | (129.88M) | (167.77M) | (272.72M) | 62.6% | |
| Selling & Marketing | (135.90M) | (272.59M) | (446.44M) | (678.84M) | (919.30M) | 35.4% | |
| Depreciation & Amortization | (4.08M) | (7.47M) | (9.52M) | (17.09M) | (54.50M) | 218.9% | |
Operating Income (EBIT) | -115.04M | -68.70M | -29.45M | 61.90M | 105.61M | 70.6% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | — | — | — | — | — | — | |
| Other Income/Expenses (Net) | 4.25M | 2.99M | 7.88M | 9.81M | 18.31M | 86.7% | |
Income Before Tax | -110.80M | -65.71M | -21.57M | 71.71M | 123.92M | 72.8% | |
| Income Tax Expense | (3.14M) | (31.00K) | (1.98M) | (54.33M) | (4.44M) | -91.8% | |
Net Income | -107.66M | -65.68M | -23.55M | 126.04M | 128.37M | 1.8% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-1 | $-0 | $-0 | $1 | $1 | -1.7% | |
| Weighted Avg Shares Outstanding | 186.78M | 204.52M | 209.34M | 215.94M | 224.96M | 4.2% | |
| Weighted Avg Shares Outstanding (Diluted) | 186.78M | 204.52M | 209.34M | 236.81M | 258.23M | 9.0% | |
EBITDA | -106.72M | -58.23M | -12.06M | 88.80M | 178.43M | 100.9% |
Explore HIMS
HIMS in the Healthcare
Mid Cap